Novo Nordisk Stock Performance
as on October 2, 2026 at 2:16 pm IST
Day's Low
Day's High
$37.37$37.97
0.08%
Downside
1.52%
Upside
52 Week's Low
52 Week's High
$35.12$64.166.10%
Downside
71.55%
Upside
Novo Nordisk share price movements today
- Previous Close
- $37.91
- Open
- $37.80
- Volume
- 9.6M
- Market Cap
- $169.0B
- Dividend Yield
- 4.74%
- Day's Low - High
- $37.37 - $37.97
- 52 Week Low - High
- $35.12 - $64.16
Novo Nordisk Historical Returns
- 1 Month Return
- -20.03 %
- 3 Month Return
- -25.84 %
- 1 Year Return
- -36.33 %
- 3 Year Return
- -59.26 %
- 5 Year Return
- -21.99 %
Novo Nordisk Stock Fundamentals & Key Indicators
Check Novo Nordisk market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$169.0B
EPS (TTM)
26.23
Dividend Yield
4.74%
Quarterly Earnings Growth YOY
-0.21%
PE Ratio (TTM)
9.66
Industry PE ratio
-19.63
PEG Ratio
1.93
EBITDA
180.9B
Revenue (TTM)
329.4B
Profit Margin
80.65%
Return On Equity TTM
59.09%
Novo Nordisk vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Novo Nordisk with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| Neutral | $169.0B | -21.99% | 9.66 | 80.65% | 4.74% | |
| StrongBuy | $1.1T | 400.83% | 38.71 | 83.40% | 0.58% | |
| StrongBuy | $465.3B | 138.27% | 73.75 | 71.48% | 2.61% | |
| StrongBuy | $644.8B | 61.19% | 30.61 | 67.91% | 1.99% | |
| Buy | $368.3B | 76.67% | 115.39 | 75.38% | 2.34% |
Stock Returns calculator for Novo Nordisk Stock including INR - Dollar returns
The Novo Nordisk stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Novo Nordisk investment value today
Current value as on today
₹69,110
Returns
Returns from Novo Nordisk Stock
Dollar Impact
₹5,440 (+5.44%)
Analyst Recommendation on Novo Nordisk Stock
Based on 4 analysts
0.00%
Buy
75.00%
Hold
25.00%
Sell
Based on 4 analysts, 75% of analysts recommend a 'HOLD' rating for Novo Nordisk. Average target price of $45.99
Novo Nordisk Share Price Target
Get share price movements and forecasts by analysts on Novo Nordisk.
What analysts predicted
18.68%UPSIDE
Target Price
$45.99
Current Price
$37.4
Analyzed by
4 Analysts
High
$47
Target
$45.99
Low
$40
Novo Nordisk target price $45.99, a slight upside of 18.68% compared to current price of $37.4. According to 4 analysts rating.
Indian Investors' Interest in Novo Nordisk Stock
Investment in Novo Nordisk Shares on INDmoney has grown by 45.32% in the last 30 days, indicating increased investment activity.
Time period: to
Change:45.32% versus previous 30 day period
Search interest for Novo Nordisk Stock has increased by 8% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:8% versus previous 30 day period
Novo Nordisk Quarterly Profit & Loss
All numbers in Millions USD
Novo Nordisk Annual Profit & Loss
All numbers in Millions USD
Novo Nordisk Quarterly Cash Flow
All numbers in Millions USD
Novo Nordisk Annual Cash Flow
All numbers in Millions USD
Novo Nordisk News & Key Events
Today's Timeline - 01 October
Thu, 04:15 PM
-Novo reports 88.5% of participants achieved normal liver fat levels after 72 weeks of Wegovy treatment.
Thu, 07:12 PM
-Wegovy shows real-world weight-loss benefits; participants lost an average of 4.1% body weight after switching therapies.
Insights on Novo Nordisk
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 3 years, Eli Lilly & Co. has given 40.2% return, outperforming this stock by 99.5%
- NO EFFECT
Against Peers
In the last 1 year, Merck & Co., Inc. has given 60.7% return, outperforming this stock by 97.0%
NEGATIVE IMPACTProfit Down
Novo-Nordisk A/S has experienced a decline in net profit over the past two quarters. The net profit decreased from $48.55 billion to $20.98 billion, resulting in an average decrease of 56.8% per quarter.
- NEGATIVE IMPACT
Revenue Fall
Novo-Nordisk A/S has experienced a decline in revenue over the last two quarters. The revenue decreased from $96.82 billion to $78.48 billion, averaging a decrease of 18.9% each quarter.
- NEGATIVE IMPACT
Price Dip
In the last 1 month, NVO stock has moved down by -20.0%
About Novo Nordisk
Novo Nordisk develops and sells medicines for diabetes, obesity and rare diseases. Its portfolio includes insulin, GLP-1 treatments and other therapies delivered through injectable and oral products. Novo Nordisk is centred on diabetes and obesity care, where manufacturing capacity, patient access and long-term clinical evidence are as important as initial demand.
How does Novo Nordisk make money?
The company earns from prescription medicine sales through wholesalers, pharmacies, hospitals and government health systems. Net revenue reflects list prices after rebates, discounts and other payments to market participants. Commercial volume and pricing are only part of the model; reimbursement, development spending and product mix determine how much reported growth reaches profit.
What drives Novo Nordisk share price?
Novo Nordisk shares are driven by prescription growth, manufacturing capacity, clinical-trial results, competition, pricing and regulatory decisions. Supply constraints and insurer coverage strongly affect obesity-drug adoption. Share-price reactions can be sharper when valuation is high, because the market is assuming strong growth and consistent execution well into the future.
What are the key revenue drivers for Novo Nordisk?
Key drivers include patient volumes for diabetes and obesity medicines, geographic expansion, new indications and production capacity. Greater supply is necessary to convert strong demand into recognised sales. Volume growth should be considered alongside pricing, supply capacity and geographic launch or contract timing, all of which can make reported growth uneven.
What could drive long-term value for Novo Nordisk?
Long-term value depends on sustaining leadership in metabolic disease while building a broader pipeline. Better formulations, additional health benefits and efficient manufacturing can extend product life, but competition and pricing pressure must be managed. The strongest long-term result would combine wider patient access with productive innovation, reliable supply and enough pricing power to fund future growth.
| Organisation | Novo Nordisk |
| Headquarters | Novo Alle 1, Bagsvaerd, CR, 2880, DK |
| Industry | Drug Manufacturers - General |
| CEO | Maziar Mike Doustdar |
Key Management of Novo Nordisk
Name | Title |
|---|---|
Ms. Tania Sabroe | EVP of People, Organisation and Corporate Affairs & Member of Management Board |
Mr. John F. Kuckelman | SVP, Group General Counsel, Global Legal, IP & Security and Member of Management Board |
Mr. Emil Kongshoej Larsen | EVP of International Operations & Member of Management Board |
Ms. Elin Jager | SVP, Chief of Staff to CEO, Corporate Strategy & Sustainability and Member of Management Board |
Mr. Jamey Millar | Executive VP of US Operations & Member of Management Board |
Ms. Hong Chow | Executive VP of Product & Portfolio Strategy and Member of Management Board |
Mr. Karsten Munk Knudsen | Executive VP, CFO & Member of the Management Board |
Dr. Martin Holst Lange | EVP of R&D, Chief Scientific Officer and Member of the Management Board |
Mr. Maziar Mike Doustdar B.A. | President, CEO & Member of the Management Board |
Ms. Thilde Hummel Bogebjerg | Executive VP of Enterprise IT & Quality and Member of Management Board |
FAQs
What is Novo Nordisk share price today?
Novo Nordisk share price today is $37.40 as on at the close of the market. Novo Nordisk share today touched a day high of $37.97 and a low of $37.37.
What is the 52 week high and 52 week low for Novo Nordisk share?
Novo Nordisk share touched a 52 week high of $64.16 on and a 52 week low of $35.12 on . Novo Nordisk stock price today i.e. is closed at $37.40,which is 41.71% down from its 52 week high and 6.49% up from its 52 week low.
What is Novo Nordisk's market capitalisation today?
Novo Nordisk market capitalisation is $0.17T as on .
How to invest in Novo Nordisk Stock (NVO) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Novo Nordisk on INDmoney app. Click on Buy button.
What is the minimum amount required to buy Novo Nordisk Stock (NVO) from India?
Indian investors can start investing in Novo Nordisk (NVO) shares with as little as ₹96.300003051758 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹963.00 in Novo Nordisk stock (as per the Rupee-Dollar exchange rate as on ).
Based on Novo Nordisk share’s latest price of $37.40 as on October 2, 2026 at 8:46 am IST, you will get 0.2674 shares of Novo Nordisk. Learn more about
fractional shares .
What are the returns that Novo Nordisk has given to Indian investors in the last 5 years?
Novo Nordisk stock has given -21.99% share price returns and 28.69% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?